Cancer Treatment
Data from Australia, Netherlands and the United Kingdom advance knowledge in cancer treatment research
Published in Cancer Weekly, August 15th, 2006
Study 1: Scientists have developed a mesothelioma vaccine using recombinant GM-CSF plus autologous tumor cells.
According to a report from Australia, "Treatments evaluated for malignant mesothelioma (MM), including chemotherapy, radiotherapy, and surgery are of limited efficacy. Immunotherapy has shown some promise in MM but optimal vaccination conditions are yet to be defined. Autologous tumor vaccines have the advantage of containing both 'self'- and 'neo'-tumor antigens but they are not commonly used in any cancer, and never in MM."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-08-15)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer invasiveness linked to low glucose levels - Carcinogenesis
Arsenic implicated in etiology of cancer - Diagnostics
Br-76-1 proposed as potential PET radiotracer for imaging solid tumors - Adenovirus Pathogenesis
Adenovirus type 2 and type 5 E1A genes are expressed at different levels - Adverse Drug Reaction
Cantharidin-induced cytotoxicity in the bladder linked to cyclooxygenase 2 expression - Adverse Drug Reaction
Chronic exposure of tumor cells to PD98059 decreased inhibitory effect - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
